Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

Please provide your email address to receive an email when new articles are posted on . CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Hassoun PM, Zamanian RT, Damico R, et al. Ambrisentan and tadalafil up-front combination therapy in scleroderma-associated pulmonary arterial hypertension. Am J Respir Crit Care Med.

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma. The recent study, published in Arthritis Care & ...

WASHINGTON, July 13 -- The lifespan for patients with scleroderma has increased significantly since the 1970s, in large measure because of a decline in deaths from renal disease. A review of data on ...

Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional ...

Scleroderma-related PAH remains a syndrome that is difficult to treat with currently available medical therapy, for reasons that are poorly understood. Although classified within the group 1 (PAH) of ...